|
|
|
Volumn , Issue 11, 1992, Pages 117-120
|
|
The Scottish trial of adjuvant tamoxifen in node-negative breast cancer. Scottish Cancer Trials Breast Group.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ESTROGEN RECEPTOR;
TAMOXIFEN;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CARCINOMA IN SITU;
CAUSE OF DEATH;
CHEMISTRY;
CLINICAL TRIAL;
COMPARATIVE STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
LIFE TABLE;
LYMPH NODE METASTASIS;
METASTASIS;
MIDDLE AGED;
MORTALITY;
PAGET NIPPLE DISEASE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SECOND CANCER;
SURVIVAL RATE;
TUMOR RECURRENCE;
UNITED KINGDOM;
ADULT;
AGED;
BREAST NEOPLASMS;
CARCINOMA IN SITU;
CARCINOMA, INTRADUCTAL, NONINFILTRATING;
CAUSE OF DEATH;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LIFE TABLES;
LYMPHATIC METASTASIS;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASMS, SECOND PRIMARY;
RECEPTORS, ESTROGEN;
RISK FACTORS;
SCOTLAND;
SURVIVAL RATE;
TAMOXIFEN;
|
|
EID: 0026477124
PISSN: 10526773
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (98)
|
|
References (0)
|
